Determination of MIC and Disk Diffusion Quality Control Guidelines for Meropenem–Vaborbactam, a Novel Carbapenem/Boronic Acid β-Lactamase Inhibitor Combination [PDF]
Meropenem–vaborbactam is a carbapenem/cyclic boronic acid β-lactamase inhibitor combination primarily active against Gram-negative bacilli, including those harboring class A serine carbapenemases such as Klebsiella pneumoniae carbapenemase (KPC).
Castanheira, Mariana +4 more
core +1 more source
Unusual association of NDM-1 with KPC-2 and armA among Brazilian Enterobacteriaceae isolates [PDF]
We report the microbiological characterization of four New Delhi metallo-beta-lactamase-1 (bla(NDM-1))-producing Enterobacteriaceae isolated in Rio de Janeiro, Brazil.
Chebabo, A. +7 more
core +1 more source
Susceptibility of Tigecycline against Carbapenem Resistant Enterobacteriaceae
Background: Enterobacteriaceae, a large family of Gram-negative bacteria, are one of the commonest etiological agents causing serious bacterial infections to humans. Carbapenems are the group of antibiotics with a broad spectrum of antimicrobial action.
Madeeha Fatima +2 more
doaj +1 more source
Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates [PDF]
David M. Livermore +6 more
openalex +1 more source
Carbapenemase-producing organisms: a global scourge [PDF]
The dramatic increase in the prevalence and clinical impact of infections caused by bacteria producing carbapenemases is a global health concern.
Bonomo, Robert A +6 more
core
A novel risk factor associated with colonization by Carbapenemase-Producing Enterobacteriaceae: Use of Proton Pump Inhibitors in addition to Antimicrobial Treatment [PDF]
published_or_final_versio
Chau, PH +11 more
core +1 more source
AIM: We aimed to evaluate the effectiveness of a modified Carbapenem Inactivation Method (CIM) in detecting carbapenemase production among different clinical Enterobacteriaceae strains.
Asiye Karakullukçu, Gökhan Aygün
doaj +1 more source
Aims and Objectives: Carbapenemase production among clinical isolates of Enterobacteriaceae has been widely reported with prevalence rates ranging from between 2.8% and 53.6%. The aim of this study was to assess the prevalence of carbapenemase production
O O Oduyebo +3 more
doaj +1 more source
Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae [PDF]
Objectives: To determine the point prevalence of carbapenem-non-susceptible Enterobacteriaceae (CNSE) and carbapenemase-producing Enterobacteriaceae (CPE) isolates among hospitalized patients in Belgium.
Berhin, Catherine +39 more
core +1 more source
Epidemiology of antibiotic resistance in culture-positive hospitalized patients in selected hospitals in Khartoum, Sudan [PDF]
Objective: To study the prevelence of antibiotic resistance and the prevalent bacterial isolates in hospitalized patients in Khartoum hospitals. Materials & Methods: A cross-sectional prevalence study was carried out during the period of April ...
Abdalrahman, Ihab B +3 more
core +4 more sources

